News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
HENNEMAN JOHN B III
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
4
| HENNEMAN JOHN B III (Director) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Granted 500 shares
@ $0
Granted 2,000 options to buy
@ $3.65, valued at
$7.3k
|
|
| 08/09/2023 |
4
| HENNEMAN JOHN B III (Director) has filed a Form 4 on R1 RCM Inc. /DE|
Txns:
| Sold 50,000 shares
@ $17.173, valued at
$858.7k
Exercised 50,000 options to buy
@ $2.61, valued at
$130.5k
|
|
| 08/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
4
| HENNEMAN JOHN B III (Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Granted 6,500 shares
@ $0 |
|
| 05/19/2023 |
4
| HENNEMAN JOHN B III (Director) has filed a Form 4 on R1 RCM Inc. /DE|
Txns:
| Granted 11,324 shares
@ $0 |
|
| 02/09/2023 |
4/A
| HENNEMAN JOHN B III (Director) has filed a Form 4 on Orthofix Medical Inc.|
Txns:
| Granted 14,354 shares
@ $0 |
|
| 01/09/2023 |
4
| HENNEMAN JOHN B III (Director) has filed a Form 4 on SeaSpine Holdings Corp|
Txns:
| Disposed/sold 82,654 shares
@ $0
Disposed/sold 58,559 options to buy
@ $15.68, valued at
$918.2k
Disposed/sold 3,858 options to buy
@ $17.18, valued at
$66.3k
Disposed/sold 13,920 options to buy
@ $9.99, valued at
$139.1k
|
|
| 01/09/2023 |
4
| HENNEMAN JOHN B III (Director) has filed a Form 4 on Orthofix Medical Inc.|
Txns:
| Granted 14,052 shares
@ $0 |
|
| 01/09/2023 |
3
| HENNEMAN JOHN B III (Director) has filed a Form 3 on Orthofix Medical Inc. |
| 08/01/2022 |
4
| HENNEMAN JOHN B III (Director) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Granted 5,995 shares
@ $0
Granted 29,575 options to buy
@ $1.09, valued at
$32.2k
|
|
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| HENNEMAN JOHN B III (Director) has filed a Form 4 on R1 RCM Inc. /DE|
Txns:
| Granted 60,790 shares
@ $0
Granted 405,111 options to buy
@ $2.61, valued at
$1.1M
Granted 12,048 options to buy
@ $2.53, valued at
$30.5k
Granted 15,385 options to buy
@ $2, valued at
$30.8k
Granted 13,762 options to buy
@ $2.42, valued at
$33.3k
Granted 14,098 options to buy
@ $2.29, valued at
$32.3k
Granted 10,512 options to buy
@ $3.08, valued at
$32.4k
Granted 9,678 options to buy
@ $3.55, valued at
$34.4k
Granted 9,169 options to buy
@ $3.76, valued at
$34.5k
Granted 7,697 options to buy
@ $4.43, valued at
$34.1k
Granted 4,770 options to buy
@ $7.07, valued at
$33.7k
|
|
| 06/23/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| HENNEMAN JOHN B III (Director) has filed a Form 4 on SeaSpine Holdings Corp|
Txns:
| Granted 15,943 shares
@ $0 |
|
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| HENNEMAN JOHN B III (Director) has filed a Form 4 on R1 RCM INC.|
Txns:
| Granted 1,965 options to buy
@ $26.69, valued at
$52.4k
|
|
| 01/04/2022 |
4
| HENNEMAN JOHN B III (Director) has filed a Form 4 on R1 RCM INC.|
Txns:
| Granted 1,424 options to buy
@ $25.7, valued at
$36.6k
|
|
| 10/04/2021 |
4
| HENNEMAN JOHN B III (Director) has filed a Form 4 on R1 RCM INC.|
Txns:
| Granted 1,649 options to buy
@ $22.57, valued at
$37.2k
|
|
| 07/01/2021 |
4
| HENNEMAN JOHN B III (Director) has filed a Form 4 on R1 RCM INC.|
Txns:
| Granted 1,660 options to buy
@ $22.46, valued at
$37.3k
|
|
| 07/01/2021 |
4
| HENNEMAN JOHN B III (Director) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Granted 4,610 shares
@ $0
Granted 22,750 options to buy
@ $4.88, valued at
$111k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
4
| HENNEMAN JOHN B III (Director) has filed a Form 4 on R1 RCM INC.|
Txns:
| Granted 1,490 options to buy
@ $24.98, valued at
$37.2k
|
|
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2020 |
4
| HENNEMAN JOHN B III (Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Granted 9,310 shares
@ $0 |
|
| 09/08/2020 |
3
| HENNEMAN JOHN B III (Director) has filed a Form 3 on Anika Therapeutics, Inc. |
| 08/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2020 |
4
| HENNEMAN JOHN B III (Director) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Granted 5,600 options to buy
@ $38.78, valued at
$217.2k
|
|
|
|
|